Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats

• Päätekijät: Yuyan Fan (Tekijä), Hongyu Fan (Tekijä), Bin Zhu (Tekijä), Yilun Zhou (Tekijä), Qingshan Liu (Tekijä), Ping Li (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2019-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Astragaloside IV (AS-IV) was reported to play a role in improving diabetic nephropathy (DN), however, the underlying mechanisms still remain unclear. The aim of the present study is to investigate whether AS-IV ameliorates DN via the regulation of endothelial nitric oxide synthas...